Badgley, Phelps & Bell’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $849K | Sell |
20,272
-1,540
| -7% | -$64.5K | 0.03% | 140 |
|
|
2021
Q1 | $735K | Sell |
21,812
-900
| -4% | -$30.3K | 0.03% | 140 |
|
|
2020
Q4 | $793K | Buy |
22,712
+2,050
| +10% | +$71.6K | 0.03% | 140 |
|
|
2020
Q3 | $717K | Hold |
20,662
| – | – | 0.04% | 138 |
|
|
2020
Q2 | $676K | Hold |
20,662
| – | – | 0.04% | 131 |
|
|
2020
Q1 | $622K | Hold |
20,662
| – | – | 0.04% | 122 |
|
|
2019
Q4 | $598K | Buy |
20,662
+450
| +2% | +$13K | 0.03% | 137 |
|
|
2019
Q3 | $522K | Sell |
20,212
-3,400
| -14% | -$87.8K | 0.03% | 140 |
|
|
2019
Q2 | $603K | Sell |
23,612
-1,300
| -5% | -$33.2K | 0.04% | 137 |
|
|
2019
Q1 | $652K | Hold |
24,912
| – | – | 0.04% | 130 |
|
|
2018
Q4 | $574K | Sell |
24,912
-268
| -1% | -$6.18K | 0.04% | 130 |
|
|
2018
Q3 | $593K | Buy |
25,180
+400
| +2% | +$9.42K | 0.04% | 134 |
|
|
2018
Q2 | $571K | Sell |
24,780
-500
| -2% | -$11.5K | 0.04% | 135 |
|
|
2018
Q1 | $623K | Buy |
25,280
+800
| +3% | +$19.7K | 0.04% | 129 |
|
|
2017
Q4 | $657K | Buy |
+24,480
| New | +$657K | 0.05% | 130 |
|